Evidence map›Paper›PMID 37304290›Full record

ArticleFrontiers in immunology2023

Yeast cell wall extracts from

Mark Rawling, Marion Schiavone, Emmanuelle Apper, Daniel L Merrifield, Mathieu Castex, Eric Leclercq, Andrew Foey

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Field Studies on theVeterinary sciences · 2026
    Article
  3. Yeast as a Model for Human Disease.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Production of β-Glucans byInternational journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Modulation of Zebrafish (Microorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mark RawlingAquatic Animal Nutrition and Health Research Group, School of Biological, Plymouth University, Plymouth, United Kingdom.
Marion SchiavoneLallemand SAS, Blagnac, France.
Emmanuelle ApperLallemand SAS, Blagnac, France.
Daniel L MerrifieldAquatic Animal Nutrition and Health Research Group, School of Biological, Plymouth University, Plymouth, United Kingdom.
Mathieu CastexLallemand SAS, Blagnac, France.
Eric LeclercqLallemand SAS, Blagnac, France.
Andrew FoeyAquatic Animal Nutrition and Health Research Group, School of Biological, Plymouth University, Plymouth, United Kingdom.
Lallemand (France) · FRUniversity of Plymouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rising awareness of antimicrobial resistance, the development and use of functional feed additives (FFAs) as an alternative prophylactic approach to improve animal health and performance is increasing. Although the FFAs from yeasts are widely used in animal and human pharma applications already, the success of future candidates resides in linking their structural functional properties to their efficacy

Indexed as

Saccharomyces cerevisiaeZebrafishAnimalsCell WallHumansImmunity, InnateIntestinal MucosaIntestinesMannansPlant ExtractsMannansPlant ExtractsBioactivitiesyeast cell wall polysaccharideszebrafishα-mannansβ-1,3-glucans

Identifiers

PMID37304290
PMCPMC10248512
OpenAlexW4378232129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.